Jefferies initiates coverage on Avanir Pharmaceuticals (NASDAQ: AVNR) with a Hold rating and $3.50 price target.

The firm states ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE